{"id":"CHEMBL1079742","canonicalSmiles":"C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1.Cl","inchiKey":"GTTBEUCJPZQMDZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERLOTINIB HYDROCHLORIDE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL553","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Erlotinib hydrochloride","Tarceva"],"synonyms":["CP-358","CP-358,774-01","CP-358774-01","Erlotinib hcl","Erlotinib hydrochloride","OSI-774"],"crossReferences":{"DailyMed":["erlotinib%20hydrochloride"],"PubChem":["534851"],"chEBI":["53509"]},"linkedTargets":{"rows":["ENSG00000146648"],"count":1},"linkedDiseases":{"rows":["MONDO_0044926","EFO_0000365","EFO_0000756","EFO_0000571","EFO_0000681","MONDO_0045056","EFO_1000657","EFO_0000308","EFO_0000632","EFO_1001951","EFO_0000588","MONDO_0002974","MONDO_0003268","Orphanet_733","MONDO_0008903","EFO_0000182","MONDO_0020634","EFO_0002618","MONDO_0008170","MONDO_0004986","MONDO_0008315","MONDO_0002691","EFO_0001422","EFO_0005567","EFO_0005537","EFO_0000233","EFO_0006544","EFO_1000142","EFO_1000172","EFO_1001465","MONDO_0007254","EFO_0000708","MONDO_0021063","MONDO_0002087","EFO_0000305","MONDO_0001187","MONDO_0002158","EFO_1000044","MONDO_0002898","EFO_0002499","EFO_1000158","EFO_0000616","EFO_0006859","MONDO_0007576","MONDO_0000521","EFO_0000313","EFO_0002501","EFO_0003060","EFO_0000311","EFO_0000640","MONDO_0002529","MONDO_0011962","MONDO_0002367","EFO_0003050","EFO_0000691","EFO_0000519","MONDO_0024880","MONDO_0021637","EFO_0000181","EFO_0003833"],"count":60},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for non-small cell lung carcinoma and has 50 investigational indications."}
{"id":"CHEMBL1083993","canonicalSmiles":"CCCCc1oc2ccccc2c1C(=O)c1cc(I)c(OCCN(CC)CC)c(I)c1.Cl","inchiKey":"ITPDYQOUSLNIHG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"AMIODARONE HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL633","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amidox","Amiodarone hydrochloride","Amyben","Cordarone","Cordarone x","Cordarone x 100","Cordarone x 200","Darmil","Nexterone","Pacerone"],"synonyms":["Amiodar","Amiodarone","Amiodarone hcl","Amiodarone hydrochloride","L-3428","Miodaron","NSC-343341","NSC-85442","Ortacrone","Ritmocardyl","SK&F-33134-A","SKF 33134-A","SKF-33134-A","Trangorex","VF-236"],"crossReferences":{"DailyMed":["amiodarone%20hydrochloride"],"PubChem":["144207027","144210713","26747445","50105848","50105849","50105850","552042","56422901","855533"]},"linkedTargets":{"rows":["ENSG00000055118"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004287","EFO_0005306","EFO_0003144","EFO_0005529","HP_0004308","Orphanet_85443"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL110458","canonicalSmiles":"OC[C@H]1NC[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"LXBIFEVIBLOUGU-DPYQTVNSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIGALASTAT","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["At-1001, gr-181314a","Galafold"],"synonyms":["Migalastat"],"crossReferences":{"DailyMed":["migalastat%20hydrochloride"],"PubChem":["11114003"],"drugbank":["DB05018"]},"childChemblIds":["CHEMBL2107355"],"linkedTargets":{"rows":["ENSG00000102393"],"count":1},"linkedDiseases":{"rows":["Orphanet_324"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for fabry disease and has 1 investigational indication."}
{"id":"CHEMBL1169388","canonicalSmiles":"CNCC[C@H](Oc1ccc(C(F)(F)F)cc1)c1ccccc1","inchiKey":"RTHCYVBBDHJXIQ-INIZCTEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-Fluoxetine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Fluoxetine"],"crossReferences":{"PubChem":["11111168","11111169","11111170","11112803","11113795","124880077","50100239","50111077","90341706"],"drugbank":["DB08544"],"chEBI":["86992"]},"childChemblIds":["CHEMBL1257031"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1173055","canonicalSmiles":"CNCc1ccc(-c2[nH]c3cc(F)cc4c3c2CCNC4=O)cc1","inchiKey":"HMABYWSNWIZPAG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUCAPARIB","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["AG-014699","AG-14447","Rucaparib"],"crossReferences":{"DailyMed":["rucaparib%20camsylate"],"PubChem":["103905261","137276017","174006354"],"drugbank":["DB12332"]},"childChemblIds":["CHEMBL2105733","CHEMBL3833368"],"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484","ENSG00000041880"],"count":3},"linkedDiseases":{"rows":["EFO_0000616","EFO_0002618","MONDO_0003060","Orphanet_145","EFO_0001075","MONDO_0008170","MONDO_0007254","MONDO_0002087","MONDO_0008315","EFO_0003060","EFO_0000311","MONDO_0001056","MONDO_0002158","EFO_0000588","EFO_0000564","MONDO_0002974","EFO_0002517","MONDO_0011962","EFO_0000673","EFO_0000702","EFO_1000613"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 4 approved and 19 investigational indications."}
{"id":"CHEMBL1200443","drugType":"Small molecule","blackBoxWarning":false,"name":"MERETHOXYLLINE PROCAINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Merethoxyline procaine","Merethoxylline procaine","Procaine merethoxylline"],"crossReferences":{"DrugCentral":["4992"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200910","canonicalSmiles":"CC(=O)N(c1onc(C)c1C)S(=O)(=O)c1ccc(N)cc1","inchiKey":"JFNWFXVFBDDWCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFISOXAZOLE ACETYL","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gantrisin","Gantrisin pediatric","Lipo gantrisin"],"synonyms":["Acetyl sulfafurazole","Acetyl sulfisoxazole","Acetylsulfafurazole","Acetylsulfisoxazole","NSC-759138","Sulfafurazole acetyl","Sulfisoxazole acetyl","Sulfisoxizole acetyl"],"crossReferences":{"DailyMed":["sulfisoxazole%20acetyl"],"PubChem":["170465159"],"drugbank":["DB14033"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953."}
{"id":"CHEMBL1200949","canonicalSmiles":"Cl.NCCc1cc[nH]n1","inchiKey":"HLJRAERMLKNULP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAZOLE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201323","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Histalog"],"synonyms":["Ametazole","Betazole dihydrochloride","Betazole hcl","Betazole hydrochloride","Betazolium chloride","NSC-759872"],"crossReferences":{"PubChem":["144204280","170465002","56463652"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200979","canonicalSmiles":"CC(C)(CO)[C@@H](O)C(=O)NCCCO","inchiKey":"SNPLKNRPJHDVJA-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXPANTHENOL","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D-panthenol 50","Ilopan","Motilyn"],"synonyms":["(+)-panthenol","D-panthenol","D-pantothenyl alcohol","Dexpanthenol","Pantothenol"],"crossReferences":{"PubChem":["170464647"],"Wikipedia":["Panthenol"],"drugbank":["DB09357"],"chEBI":["27373"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and is indicated for skin ulcer and eye disease and has 4 investigational indications."}
{"id":"CHEMBL1201248","canonicalSmiles":"COc1ccc(C[C@@H]2c3cc(OC)c(OC)cc3CC[N@+]2(C)CCC(=O)OCCCCCOC(=O)CC[N@@+]2(C)CCc3cc(OC)c(OC)cc3[C@H]2Cc2ccc(OC)c(OC)c2)cc1OC","inchiKey":"YXSLJKQTIDHPOT-LJCJQEJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CISATRACURIUM","yearOfFirstApproval":1995,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nimbex"],"synonyms":["Cisatracurium","Cisatracurium cation","Cisatracurium ion"],"crossReferences":{"DailyMed":["cisatracurium%20besylate"],"Wikipedia":["Cisatracurium_besilate"],"drugbank":["DB00565"]},"childChemblIds":["CHEMBL1200641"],"linkedTargets":{"rows":["ENSG00000170175","ENSG00000138435","ENSG00000135902","ENSG00000108556","ENSG00000196811"],"count":5},"linkedDiseases":{"rows":["EFO_0000694","EFO_1000992","MONDO_0100130","EFO_0005323","EFO_1001905","EFO_1000637","EFO_0003843"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1995 and has 1 investigational indication."}
{"id":"CHEMBL1201468","drugType":"Small molecule","blackBoxWarning":true,"name":"ESTROGENS, ESTERIFIED","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amnestrogen","Esterified estrogens","Estratab","Evex","Femogen","Menest"],"synonyms":["Esterified estrogens","Estrogens esterified","Estrogens, esterified","Estrogens,esterified"],"crossReferences":{"DailyMed":["estrogens,%20esterified"]},"linkedTargets":{"rows":["ENSG00000091831","ENSG00000140009"],"count":2},"linkedDiseases":{"rows":["MONDO_0002146","EFO_0004266","MONDO_0007254","EFO_1000096","EFO_0003922"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1977 and has 5 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201718","drugType":"Enzyme","blackBoxWarning":false,"name":"HYALURONIDASE (HUMAN RECOMBINANT)","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cumulase","Hylenex","Hylenex recombinant"],"synonyms":["Chemophase","Enhanze","Human hyaluronidase","Hyaluronidase (human recombinant)","Hyaluronidase (human)","Hyaluronidase human recombinant","Hyaluronidase recombinant human","Hyaluronidase, human","Hyaluronidase, human recombinant","Hyaluronidase-fihj","Hyaluronidase-oysk","Hyaluronidase-zzxf","RHUPH-20","RHUPH20","Vorhyaluronidase alfa"],"crossReferences":{"DailyMed":["hyaluronidase%20(human%20recombinant)","hyaluronidase%20recombinant%20human"]},"description":"Enzyme drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 17 investigational indications."}
{"id":"CHEMBL1201772","canonicalSmiles":"CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2","inchiKey":"DTGLZDAWLRGWQN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PRASUGREL","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Efient"],"synonyms":["LY-640315","NSC-759625","Prasugrel"],"crossReferences":{"DailyMed":["prasugrel%20hydrochloride"],"PubChem":["124899264","174006898"],"Wikipedia":["Prasugrel"],"drugbank":["DB06209"],"chEBI":["87723"]},"childChemblIds":["CHEMBL1201773"],"linkedTargets":{"rows":["ENSG00000169313"],"count":1},"linkedDiseases":{"rows":["EFO_0003777","EFO_0000275","Orphanet_232","EFO_0001645","EFO_0000319","EFO_0003913","EFO_0003106","HP_0100806","MP_0001914","MONDO_0100096","EFO_0008585","EFO_0003870","EFO_0000764","EFO_0003884","EFO_0008583","EFO_0007328","EFO_0000612","HP_0004419","MONDO_0004979","EFO_1001207","EFO_0000400","EFO_0005672"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 4 approved and 10 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1231606","canonicalSmiles":"COc1cccc(Cc2c[nH]c3ncccc23)c1","inchiKey":"GHQCCHWTDLTMJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231606","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07525"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232381","canonicalSmiles":"C[C@@H]1NC(=O)N[C@@H]1CCCCCC(=O)O","inchiKey":"AUTOLBMXDDTRRT-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1232381","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193703"],"drugbank":["DB03775"],"chEBI":["42280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234354","canonicalSmiles":"COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1","inchiKey":"XDLYKKIQACFMJG-WKILWMFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PF-04691502","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PF-04691502","PF-4691502","Pf-04691502"],"crossReferences":{"drugbank":["DB11974"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0003869","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1236282","canonicalSmiles":"CS(=O)(=O)c1ccc([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)cc1","inchiKey":"OTVAEFIXJLOWRX-NXEZZACHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIAMPHENICOL","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Thiocymetin"],"synonyms":["Armai","Dextrosulphenidol","NSC-522822","Thiamphenicol","Thiamphenicol aminoacetate hydrochloride","Thiophenicol","WIN 5063-2","WIN-5063-2"],"crossReferences":{"PubChem":["144204128","144208014","170465845","56320856"],"Wikipedia":["Thiamphenicol"],"drugbank":["DB08621"],"chEBI":["32215"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL126159","canonicalSmiles":"COc1cc2c3c(n(CCCNCCO)c(=O)c2cc1OC)-c1cc2c(cc1C3=O)OCO2","inchiKey":"QCSDJDQOJBQTDV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LMP-744","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lmp-744","Lmp744","MJ-III-65","NSC-706743","NSC-706744","Topoisomerase-1 inhibitor lmp744"],"childChemblIds":["CHEMBL332003"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1318150","canonicalSmiles":"CNC(=O)C[C@@H](N)C(=O)N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12)c1ccc(O)cc1","inchiKey":"BHELIUBJHYAEDK-OAIUPTLZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPOXICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aspoxicillin","Doyle"],"crossReferences":{"PubChem":["144206363","50125944"],"drugbank":["DB13816"],"chEBI":["31240"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1408759","canonicalSmiles":"Cc1ccc(C(C)C)cc2c(C)ccc1-2","inchiKey":"FWKQNCXZGNBPFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUAIAZULEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Guaiazulen","Guaiazulene","Kessazulen","NSC-4714","Purazulen","S-guaiazulene","Silazulon","Uroazulen","Vaumigan","Vetivazulen"],"crossReferences":{"PubChem":["170465862","26749853","29215182","93576737"],"drugbank":["DB13329"],"chEBI":["5550"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1423","canonicalSmiles":"O=c1[nH]c2ccccc2n1C1CCN(CCCC(c2ccc(F)cc2)c2ccc(F)cc2)CC1","inchiKey":"YVUQSNJEYSNKRX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMOZIDE","yearOfFirstApproval":1984,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Orap","Pimozide"],"synonyms":["MCN-JR-6238","NSC-170984","Pimozide","R 623","R 6238","R-623","R-6238"],"crossReferences":{"DailyMed":["pimozide"],"PubChem":["104171210","11111615","11112507","11113804","124881071","124881072","124881075","124881079","144116849","144203775","144211903","170464864","26747138","26751488","26751978","26751979","50104653","563187","56422165","85231181","855710","90341263"],"Wikipedia":["Pimozide"],"drugbank":["DB01100"],"chEBI":["8212"]},"linkedTargets":{"rows":["ENSG00000184845","ENSG00000069696","ENSG00000149295","ENSG00000102468","ENSG00000151577","ENSG00000169676"],"count":6},"linkedDiseases":{"rows":["MONDO_0005090","MONDO_0002050","HP_0000726","EFO_0004895","EFO_0000677","EFO_0005407","MONDO_0004976","EFO_0005230","EFO_0005411"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1984 and is indicated for psychosis and tourette syndrome and has 5 investigational indications."}
{"id":"CHEMBL1443577","canonicalSmiles":"Nc1ccc(S(=O)(=O)Nc2ccc(Cl)nn2)cc1","inchiKey":"XOXHILFPRYWFOD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULFACHLORPYRIDAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Nefrosul","Sonilyn"],"synonyms":["NSC-757858","Sulfachloropyridazine","Sulfachloropyridizine","Sulfachlorpyridazine","Sulphachlorpyridazine"],"crossReferences":{"PubChem":["11112212","144206510","170466574","26661030","26748511"],"drugbank":["DB11461"],"chEBI":["59057"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1476500","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(O)C[C@@H](C)C(=NOCOCCOC)[C@H](C)[C@@H](O)[C@]1(C)O","inchiKey":"RXZBMPWDPOLZGW-HITVVWEBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1476500","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204248","144206701","144212152","50086576"],"drugbank":["DB00778"],"chEBI":["48844"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1515","canonicalSmiles":"Cn1cc[nH]c1=S","inchiKey":"PMRYVIKBURPHAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHIMAZOLE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Favistan","Methimazole","Tapazole"],"synonyms":["Mercaptizole","Methimazole","NSC-38608","Thiamazole"],"crossReferences":{"DailyMed":["methimazole"],"PubChem":["11112158","144203892","144208539","144210850","170464856","57299280","8139973"],"TG-GATEs":["57"],"Wikipedia":["Methimazole"],"drugbank":["DB00763"],"chEBI":["50673"]},"linkedTargets":{"rows":["ENSG00000115705"],"count":1},"linkedDiseases":{"rows":["EFO_0000398","EFO_1001062","EFO_1001466","EFO_1001465","EFO_0009189","EFO_0000519","EFO_0004237","HP_0000820"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for abnormality of the thyroid gland and hyperthyroidism and has 3 investigational indications."}
{"id":"CHEMBL1525","canonicalSmiles":"CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1","inchiKey":"RLLPVAHGXHCWKJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERMETHRIN","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elimite","Lyclear","Lythrin","Permethrin"],"synonyms":["Activyl tick plus","NSC-760105","Permethrin"],"crossReferences":{"DailyMed":["permethrin"],"PubChem":["144205180","144208784","144211008","26754481","26754482","26754483","26754484","29215320","57260102"],"Wikipedia":["Permethrin"],"drugbank":["DB04930"],"chEBI":["34911"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for parasitic infection and has 2 investigational indications."}
{"id":"CHEMBL1528","canonicalSmiles":"[F-].[Na+]","inchiKey":"PUZPDOWCWNUUKD-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM FLUORIDE","yearOfFirstApproval":1972,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dentiplus","Duraphat","En-de-kay","Fluor ret","Fluor-a-day","Fluorigard","Fluorigard daily","Fluorigard weekly","Fluorinse","Minute-gel","Nafril ret","Neutra care","Ossin","Osteofluor","Pediaflor","Point-two","Zymafluor"],"synonyms":["Dentalfluoro","Fluoride (as sodium fluoride)","Fluoride (as sodium)","NSC-77385","Natrii fluoridum","Natrum fluoratum","Pergantene","Sodium Fluoride","Sodium fluoride","Sodium fluoride (naf)"],"crossReferences":{"DrugCentral":["4243"],"Wikipedia":["Sodium_fluoride"],"drugbank":["DB09325"],"chEBI":["28741"]},"childChemblIds":["CHEMBL1200744"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1972 and has 3 approved and 13 investigational indications."}
{"id":"CHEMBL1560","canonicalSmiles":"C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O","inchiKey":"FAKRSMQSSFJEIM-RQJHMYQMSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CAPTOPRIL","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acepril","Capoten","Captomex","Captopril","Ecopace","Hyteneze 12.5","Hyteneze 25","Hyteneze 50","Kaplon","Lopril","Noyada","Tensobon"],"synonyms":["Apopril","C09AA01","Capoten","Captomax","Captopril","Captoprilum","Farcopril","Garranil","Hypopress","Mepha","NSC-757419","SA-333","SQ -14225","SQ 14,225","SQ-14225","Tensiomin","Zapto"],"crossReferences":{"DailyMed":["captopril"],"PubChem":["11110941","144204441","170464644","26747043","26751563","50104171","50104172","50104173","50104174","56422201","855925","90340865"],"TG-GATEs":["94"],"Wikipedia":["Captopril"],"drugbank":["DB01197"],"chEBI":["3380"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003086","EFO_0003777","EFO_0001361","EFO_0000401","EFO_0000373","EFO_0003770","EFO_0000266","EFO_0000319","EFO_1002048","EFO_0005755","EFO_0000537","EFO_0002430","EFO_0003106","MONDO_0100096","EFO_0003144","EFO_0000612","MONDO_0005148","EFO_0000519","EFO_1000635","EFO_0000668"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 9 approved and 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL15844","canonicalSmiles":"c1ccc2[nH]ccc2c1","inchiKey":"SIKJAQJRHWYJAI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Indole"],"crossReferences":{"PubChem":["144206089","144208875","144213254","170465733"],"Wikipedia":["Indole"],"drugbank":["DB04532"],"chEBI":["16881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1591365","canonicalSmiles":"COc1cccc(N(C)C(=S)Oc2ccc3c(c2)CCCC3)n1","inchiKey":"VPHPQNGOVQYUMG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LIRANAFTATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Liranaftate","Piritetrate","Zefnart"],"crossReferences":{"PubChem":["144205776","170466057","174007142","26758023"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL16081","canonicalSmiles":"CC(N)=O","inchiKey":"DLFVBJFMPXGRIB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETAMIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acetamide"],"crossReferences":{"PubChem":["11110709","144211093","50105717","50105718","85230893","90341044"],"Wikipedia":["Acetamide"],"drugbank":["DB02736"],"chEBI":["27856"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1622","canonicalSmiles":"Nc1nc(=O)c2nc(CNc3ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc3)cnc2[nH]1","inchiKey":"OVBPIULPVIDEAO-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOLIC ACID","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bio science","Folic acid","Folicare","Folicet","Folsan","Folvite","Lexpec","Natur flow","Preconceive","Roche","Vitamin Bc","Vitamin M"],"synonyms":["Acidum folicum","B03BB01","Folacin","Folate","Foldine","Folettes","Foliamin","Folic Acid","Folic acid","Folipac","Incafolic","Millafol","NSC-3073","Pteroylglutamic acid","Vitamin b9","Vitamin bc","Vitamin m"],"crossReferences":{"DailyMed":["folic%20acid"],"PubChem":["11112150","144205112","144210447","170464833","26754169","50085945"],"Wikipedia":["Folic_acid"],"drugbank":["DB00158"],"chEBI":["27470"]},"childChemblIds":["CHEMBL2107429"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 10 approved and 59 investigational indications."}
{"id":"CHEMBL1683544","canonicalSmiles":"C=C1C[C@@H]2CC[C@@]34C[C@H]5O[C@H]6[C@@H](O3)[C@H]3O[C@H](CC[C@@H]3O[C@H]6[C@H]5O4)CC(=O)C[C@H]3[C@H](C[C@H]4O[C@@H](CC[C@@H]1O2)C[C@@H](C)C4=C)O[C@H](C[C@H](O)CN)[C@@H]3OC.CS(=O)(=O)O","inchiKey":"QAMYWGZHLCQOOJ-WRNBYXCMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ERIBULIN MESYLATE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1683590","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Halaven"],"synonyms":["E-7389","E7389","Eribulin (as mesylate)","Eribulin mesilate","Eribulin mesylate","Eribulin monomethanesulfonate","Halaven"],"crossReferences":{"DailyMed":["eribulin%20mesylate"],"chEBI":["70710"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0006859","EFO_0000637","MONDO_0004192","MONDO_0007254","MONDO_0004669","EFO_1001968","EFO_0000305","MONDO_0008315","EFO_0003060","EFO_0000311","MONDO_0001187","MONDO_0021632","EFO_0000304","EFO_1000044","EFO_0006861","MONDO_0002974","EFO_0005537","EFO_0008528","EFO_0000673","EFO_0000574","EFO_0006544","MONDO_0024880"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 16 investigational indications."}
{"id":"CHEMBL1691","canonicalSmiles":"CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1.Cl","inchiKey":"CHDPSNLJFOQTRK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BETAXOLOL HYDROCHLORIDE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL423","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Betaxolol","Betaxolol hydrochloride","Betoptic","Betoptic s","Kerlone"],"synonyms":["ALO 1401-02","ALO-1401-02","ALO-140102","Betaxolol hcl","Betaxolol hydrochloride","NSC-760048","SL 75.212-10","SL-75.212-10","SL-75212-10","SL-7521210"],"crossReferences":{"DailyMed":["betaxolol%20hydrochloride"],"PubChem":["26663050","50105931","855778"],"chEBI":["643228"]},"linkedTargets":{"rows":["ENSG00000043591"],"count":1},"linkedDiseases":{"rows":["EFO_0004190","EFO_1001069","EFO_0000537"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1985 and has 3 approved indications."}
{"id":"CHEMBL1729","canonicalSmiles":"COc1cc(N)c(Cl)cc1C(=O)NC1CCN(CCCOc2ccc(F)cc2)CC1OC","inchiKey":"DCSUBABJRXZOMT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CISAPRIDE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"],"year":2000},"tradeNames":["Alimix","Prepulsid","Prepulsid quicklet","Propulsid","Propulsid quicksolv"],"synonyms":["Cisapride","Cisapride monohydrate","Propulsid","R-51,619","R-51619"],"crossReferences":{"PubChem":["144204250","170465200"],"Wikipedia":["Cisapride"]},"childChemblIds":["CHEMBL1200788"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0003948","EFO_0010282","EFO_1000948","EFO_0003917"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1993 and is indicated for gastrointestinal disease. It was withdrawn in United States  in 2000 due to Cardiotoxicity. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743013","drugType":"Antibody","blackBoxWarning":false,"name":"ENSITUXIMAB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ensituximab","NEO-101","NEO-102","NPC-1C"],"linkedTargets":{"rows":["ENSG00000215182"],"count":1},"linkedDiseases":{"rows":["EFO_0002618"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1743020","drugType":"Antibody","blackBoxWarning":false,"name":"FORALUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Foralumab","NI-0401","TZLS-401"],"linkedTargets":{"rows":["ENSG00000167286","ENSG00000160654","ENSG00000198851"],"count":3},"linkedDiseases":{"rows":["MONDO_0100096","MONDO_0005301","EFO_0008520","EFO_0000384","EFO_0008522","EFO_0004599"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743065","drugType":"Antibody","blackBoxWarning":false,"name":"ROLEDUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Roledumab"],"linkedTargets":{"rows":["ENSG00000187010"],"count":1},"linkedDiseases":{"rows":["EFO_1001159"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL176","canonicalSmiles":"NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](N)[C@@H](O)[C@@H]1O","inchiKey":"SKKLOUVUUNMCJE-FQSMHNGLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BEKANAMYCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aminodeoxykanamycin","Bekanamycin","Bekanamycin sulfate","Kanamycin b","Kantrex","Klebcil","NK 1006","NK-1006","Nebramycin v"],"crossReferences":{"PubChem":["144206745"],"Wikipedia":["Bekanamycin"],"drugbank":["DB13673"],"chEBI":["28098"]},"childChemblIds":["CHEMBL1237048"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1789941","canonicalSmiles":"N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1","inchiKey":"HFNKQEVNSGCOJV-OAHLLOKOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUXOLITINIB","yearOfFirstApproval":2011,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Jakavi"],"synonyms":["INC-424","INC424","INCB-018424","INCB-18424","INCB018424","Ruxolitinib"],"crossReferences":{"DailyMed":["ruxolitinib%20phosphate"],"Wikipedia":["Ruxolitinib"],"drugbank":["DB08877"],"chEBI":["66919"]},"childChemblIds":["CHEMBL1795071","CHEMBL4594382","CHEMBL4594381"],"linkedTargets":{"rows":["ENSG00000096968","ENSG00000162434"],"count":2},"linkedDiseases":{"rows":["EFO_1000710","EFO_1001958","EFO_0005952","EFO_1000984","EFO_1001951","EFO_0000565","EFO_0004251","EFO_0000339","MONDO_0008903","MONDO_0015540","EFO_0000676","EFO_0004208","MONDO_0003540","MONDO_0013730","EFO_0002618","EFO_0000466","EFO_0000220","EFO_0001642","HP_0000964","EFO_1001806","EFO_0002429","MONDO_0008315","HP_0011974","EFO_0004192","MONDO_0100096","HP_0004326","MONDO_0002406","EFO_0000574","EFO_0001378","Orphanet_231214","MONDO_0009348","MONDO_0044903","EFO_0007183","MONDO_0004600","MONDO_0007254","EFO_0000274","EFO_0000209","EFO_0000305","EFO_0002430","EFO_0000183","EFO_1000726","EFO_1000042","EFO_0000479","EFO_1000253","EFO_0000616","EFO_0000694","EFO_0000685","EFO_1001779","MONDO_0019457","EFO_0000222","MONDO_0019558","EFO_0004599","EFO_0003060","EFO_0000311","EFO_0003106","EFO_1000738","EFO_0001068","EFO_0000095","EFO_0000764","EFO_1001467","EFO_1001927","MONDO_0024880","EFO_0000519","EFO_0000181","EFO_1000494"],"count":65},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2011 and has 5 approved and 55 investigational indications."}
{"id":"CHEMBL1823817","canonicalSmiles":"COC[C@H](O)Cn1c(=O)cnn(-c2ccc(Cl)c(C(=O)NCC3(O)CCCCCC3)c2)c1=O","inchiKey":"FUCKCIVGBCBZNP-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CE-224535","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CE 224,535","CE-224,535","Ce-224535"],"crossReferences":{"drugbank":["DB12113"]},"linkedTargets":{"rows":["ENSG00000089041"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005178"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1908324","canonicalSmiles":"C=N[C@@H](C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)O)C(C)(C)S[C@H]12)c1ccccc1","inchiKey":"FZECHKJQHUVANE-MCYUEQNJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METAMPICILLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fedacilina","Metampicillin","Methylenampicillin","Micinovo","NSC-758167","Pravacilin","Ruticina","Viderpen"],"crossReferences":{"drugbank":["DB13836"],"chEBI":["52060"]},"childChemblIds":["CHEMBL3138613"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1956285","canonicalSmiles":"Cc1cc(Nc2ccc(S(F)(F)(F)(F)F)cc2)n2nc(C(C)(F)F)nc2n1","inchiKey":"OIZSVTOIBNSVOS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DSM-265","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DSM265","Dsm-265","Dsm265"],"crossReferences":{"drugbank":["DB12397"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1964120","drugType":"Enzyme","blackBoxWarning":false,"name":"TALIGLUCERASE ALFA","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elelyso"],"synonyms":["PRGC-D","PRGCD","PRX-112","Taliglucerase alfa","Uplyso"],"crossReferences":{"DailyMed":["taliglucerase%20alfa"],"DrugCentral":["5199"]},"description":"Enzyme drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for gaucher disease."}
{"id":"CHEMBL1972860","canonicalSmiles":"CN(NC(=O)CC(=O)NN(C)C(=S)c1ccccc1)C(=S)c1ccccc1","inchiKey":"BKJIXTWSNXCKJH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELESCLOMOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Elesclomol","GSK-842879","GSK-842879A","STA-4783"],"crossReferences":{"PubChem":["137275831","445356"],"Wikipedia":["Elesclomol"],"drugbank":["DB05719"],"chEBI":["79369"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL2104414","canonicalSmiles":"CCc1c(CC)c2cc3nc(cnc4cc(OCCOCCOCCOC)c(OCCOCCOCCOC)cc4ncc4nc(cc1[nH]2)C(CCCO)=C4C)C(C)=C3CCCO","inchiKey":"AHNIKTNNZJNCFN-CNEPGKQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MOTEXAFIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Motexafin"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104765","canonicalSmiles":"C[C@H](O)C(=O)[C@@]1(C)CC[C@H]2[C@@H]3CCC4=CC(=O)CCC4=C3CC[C@@]21C","inchiKey":"JUNDJWOLDSCTFK-MTZCLOFQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMEGESTONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RU 27987","RU-27987","Trimegestone"],"crossReferences":{"drugbank":["DB13129"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104790","canonicalSmiles":"COc1ccccc1OCC1CNC(=O)O1","inchiKey":"ZMNSRFNUONFLSP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEPHENOXALONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lenetran"],"synonyms":["AHR-233","Dorsiflex","Mefenoxalone","Mephenoxalone","Methoxadone","Methoxydone","Metoxadone","OM-518"],"crossReferences":{"PubChem":["144206700","170466491"],"drugbank":["DB13754"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104864","canonicalSmiles":"O=C(O)/C=C/C(=O)O.O=C1Cc2c(ccc3c2O[C@@H](CNCc2ccccc2)CO3)N1","inchiKey":"GELJVTSEGKGLDF-QDSMGTAFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APLINDORE FUMARATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2110659","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aplindore fumarate","DAB-452","Palindore","Palindore fumarate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2104932","canonicalSmiles":"CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C(F)(F)F)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"CDZJOBWKHSYNMO-SCUQKFFVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUMEDROXONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flumedroxone","WG 537 [AS ACETATE]"],"crossReferences":{"drugbank":["DB13610"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2104981","canonicalSmiles":"COCCN1CCC(N(Cc2ccc(-c3ccc(C(F)(F)F)cc3)cc2)C(=O)Cn2c(SCc3cccc(F)c3F)cc(=O)c3ccccc32)CC1","inchiKey":"NNBGCSGCRSCFEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RILAPLADIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rilapladib","SB-659032"],"crossReferences":{"drugbank":["DB05119"]},"linkedTargets":{"rows":["ENSG00000146070"],"count":1},"linkedDiseases":{"rows":["EFO_0003914","MONDO_0004975"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105075","canonicalSmiles":"O=C(OCC(O)CO)c1ccccc1Nc1ccnc2c(C(F)(F)F)cccc12","inchiKey":"APQPGQGAWABJLN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLOCTAFENINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Idarac"],"synonyms":["Diralgan","Floctafenin","Floctafenine","Idalon","Novodolan","R 4318","R-4138","R-4318","RU 15750","RU-15750"],"crossReferences":{"PubChem":["170465681"],"drugbank":["DB08976"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105686","canonicalSmiles":"CCCCOCCOc1ccc(-c2ccc3c(c2)/C=C(/C(=O)Nc2ccc([S@@+]([O-])Cc4cncn4CCC)cc2)CCCN3CC(C)C)cc1.CS(=O)(=O)O","inchiKey":"IXPBPUPDRDCRSY-YLZLUMLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CENICRIVIROC MESYLATE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL2110727","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenicriviroc mesilate","Cenicriviroc mesylate","TAK-652","TBR-652"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2106309","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)COC(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"MFBMYAOAMQLLPK-FZNHGJLXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE ACEPONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cortavance","Efficort","Hydrocortisone aceponate"],"crossReferences":{"drugbank":["DB14538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107333","canonicalSmiles":"COC(=O)/C=C/C(=O)OC","inchiKey":"LDCRTTXIJACKKU-ONEGZZNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL FUMARATE","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tecfidera"],"synonyms":["AZL 0 211089","AZL O 211089","AZL-0211089","AZL-O-211089","BG 00012","BG 12","BG-00012","BG-12","BG00012","Dimethyl fumar","Dimethyl fumarate","FAG-201","FP-187","FP187","Fumaric acid dimethyl ester","LAS-41008","LAS41008","Las41008","NSC-167432","NSC-25942","Panaclar"],"crossReferences":{"DailyMed":["dimethyl%20fumarate"],"drugbank":["DB08908"],"chEBI":["76004"]},"linkedTargets":{"rows":["ENSG00000079999"],"count":1},"linkedDiseases":{"rows":["EFO_0000694","EFO_0000685","HP_0002140","EFO_0001365","EFO_0002913","EFO_1001465","EFO_0003778","EFO_0003929","EFO_0005669","EFO_0000540","EFO_0003840","MONDO_0005301","EFO_0000095","EFO_0008520","EFO_0000676","EFO_0003918"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for multiple sclerosis and immune system disease and has 13 investigational indications."}
{"id":"CHEMBL2107873","drugType":"Protein","blackBoxWarning":false,"name":"VONICOG ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAX 111","BAX-111","Von willebrand factor (recombinant)","Vonicog alfa","Vonvendi"],"crossReferences":{"DrugCentral":["5173"]},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2108058","drugType":"Protein","blackBoxWarning":false,"name":"VANUTIDE CRIDIFICAR","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACC-001","Vanutide cridificar"],"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108278","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"ETEPLIRSEN","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Exondys 51"],"synonyms":["AVI-4658","Eteplirsen"],"crossReferences":{"DailyMed":["eteplirsen"],"DrugCentral":["5182"]},"linkedTargets":{"rows":["ENSG00000198947"],"count":1},"linkedDiseases":{"rows":["Orphanet_98896","Orphanet_98473"],"count":2},"description":"Oligonucleotide drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for muscular dystrophy and duchenne muscular dystrophy."}
{"id":"CHEMBL2108291","drugType":"Protein","blackBoxWarning":false,"name":"METENKEFALIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(met5)-enkephalin","Enkephalin-(5-l-methionine)","Inno-105","Met-enkephalin","Metenkefalin","Methionine enkephalin","NSC-374896","Opioid growth factor","Sh-pentapeptide-19","Tyr-gly-gly-phe-met"],"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108557","drugType":"Protein","blackBoxWarning":false,"name":"TELBERMIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["RH VEGF","RH-VEGF","RHVEG-F","RHVEGF","SNN0029","Telbermin","Vegf-a165","Vegf165"],"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755"],"count":2},"linkedDiseases":{"rows":["EFO_1001459","MONDO_0004976"],"count":2},"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108816","drugType":"Unknown","blackBoxWarning":false,"name":"YELLOW FEVER VACCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Yf-vax"],"synonyms":["FLAVIVIRUS YELLOW FEVER VIRUS 17D-204 WHOLE","Stamaril","Yellow fever vaccine","Yellow fever, live attenuated"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109092","drugType":"Protein","blackBoxWarning":false,"name":"EPOETIN BETA","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Marogen","Neorecormon","Neorecormon 1000","Neorecormon 10000","Neorecormon 2000","Neorecormon 20000","Neorecormon 3000","Neorecormon 30000","Neorecormon 4000","Neorecormon 500","Neorecormon 5000","Neorecormon 6000","Recormon 1000","Recormon 10000","Recormon 2000","Recormon 5000","Recormon s 1000","Recormon s 10000","Recormon s 2000","Recormon s 5000"],"synonyms":["BM 06.019","EPOCH","Epoetin","Epoetin beta","Erythropoietin","Erythropoietin for bioassays"],"crossReferences":{"DrugCentral":["5160"]},"linkedTargets":{"rows":["ENSG00000187266"],"count":1},"linkedDiseases":{"rows":["EFO_0007405","EFO_1000809","EFO_0000401","EFO_1001919","MONDO_0002135","EFO_1002048","EFO_0003964","EFO_0005676","MONDO_0003608","EFO_0004247","MONDO_0002158","EFO_1001375","EFO_1000824","EFO_0000712","EFO_0003884","MONDO_0005299","EFO_0003144","EFO_1000632","EFO_0004272","MONDO_0005180","EFO_0007332","EFO_0000183","MONDO_0004976","EFO_0003917","EFO_0009321","EFO_0000198","EFO_1001779","EFO_0003928","EFO_0006859","EFO_1001330","HP_0002140","EFO_0002687","EFO_0008572","HP_0001919","MONDO_0008170","EFO_0000403","EFO_1000782","EFO_0004599","EFO_0000311","EFO_0000546","MP_0001914","EFO_0004220","EFO_0000713","EFO_0001061","MONDO_0005301","EFO_1001100","EFO_0001068","EFO_0000764","EFO_0004273","EFO_0000574","EFO_0008583","EFO_0001425","EFO_0000612","MONDO_0043510","MONDO_0005178"],"count":55},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) and is indicated for anemia (phenotype) and has 44 investigational indications."}
{"id":"CHEMBL2109440","drugType":"Antibody","blackBoxWarning":false,"name":"LY-2787106","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-2787106","LY2787106","Ly-2787106"],"linkedTargets":{"rows":["ENSG00000105697"],"count":1},"linkedDiseases":{"rows":["EFO_0004272"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109564","drugType":"Antibody","blackBoxWarning":false,"name":"CL-184","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CL-184","CR-57/CR-4098","Cl-184","MIX OF CR-57 AND CR-4098"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2109646","drugType":"Antibody","blackBoxWarning":false,"name":"REGN-1154","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["REGN-1154"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2110563","drugType":"Small molecule","blackBoxWarning":false,"name":"CYANOCOBALAMIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Behepan","Berubigen","Betalin 12","Calomist","Cobavite","Cyanocobalamin","Cyanovit-b12","Cytacon","Cytamen","Dodex","Nascobal","Redisol","Rubivite","Rubramin","Rubramin pc","Ruvite","Vi-twel","Vibalt","Vibisone","Vitamin B 12"],"synonyms":["Antipernicin","Cyanocobalamin","Cyanocobalaminum","Cyanocobalmin","Cycobemin","Dodecavite","NSC-80365","Normocytin","Plecyamin","Rubivamine","Vitamin b 12","Vitamin b(bdi1)(bdi2)","Vitamin b-12","Vitamin b12","Vitamin b12 (as cyanocobalamin )","Vitamin b12 nos"],"crossReferences":{"DailyMed":["cyanocobalamin"],"DrugCentral":["4196"]},"childChemblIds":["CHEMBL2096655","CHEMBL2104381","CHEMBL2104118"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 9 approved and 35 investigational indications."}
{"id":"CHEMBL2110585","canonicalSmiles":"CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c1ccccc1","inchiKey":"GWEJFLVSOGNLSS-WPFOTENUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EZATIOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ezatiostat","TLK-199"],"crossReferences":{"drugbank":["DB05460"]},"childChemblIds":["CHEMBL2103810"],"linkedTargets":{"rows":["ENSG00000084207"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0001475","EFO_0003060"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2110900","canonicalSmiles":"CN(C)[C@@H](CCOc1cccc2ccccc12)c1ccccc1","inchiKey":"USRHYDPUVLEVMC-FQEVSTJZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAPOXETINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dapoxetine","Kutub","LY-210448"],"crossReferences":{"PubChem":["170466555"],"drugbank":["DB04884"]},"childChemblIds":["CHEMBL2106574"],"linkedTargets":{"rows":["ENSG00000108576"],"count":1},"linkedDiseases":{"rows":["EFO_0004714","EFO_0004234"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL224325","canonicalSmiles":"Cc1ccc2c(Cl)cc(Cl)c(O)c2n1","inchiKey":"GPTXWRGISTZRIO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLORQUINALDOL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Steroxin"],"synonyms":["Chlorquinaldol","Clorquinaldol","NSC-755830"],"crossReferences":{"PubChem":["124891968","144207039","170465701","26749812","29215181","89854495"],"Wikipedia":["Chlorquinaldol"],"drugbank":["DB13306"],"chEBI":["74500"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL227711","canonicalSmiles":"O=c1ccn([C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c(=O)[nH]1","inchiKey":"HSCJRCZFDFQWRP-NYYOCOOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL227711","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02421"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2304041","canonicalSmiles":"C=CC[C@H]1C(=O)C(C)(C)[C@@H](O)CC(=O)O[C@H](c2ccc3sc(C)nc3c2)C[C@@H]2O[C@]2(C)CCC[C@H](C)[C@@H]1O","inchiKey":"BFZKMNSQCNVFGM-UCEYFQQTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAGOPILONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAY86-5302","DE-03757","Sagopilone","ZK 219477","ZK-219477"],"crossReferences":{"drugbank":["DB12391"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000167553","ENSG00000127824","ENSG00000188229","ENSG00000198033","ENSG00000258947","ENSG00000152086","ENSG00000196230","ENSG00000104833","ENSG00000137267","ENSG00000167552","ENSG00000101162","ENSG00000123416","ENSG00000137285","ENSG00000176014"],"count":15},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0003893","EFO_0000756","EFO_0000702","MONDO_0007254","MONDO_0008315","EFO_0003060","EFO_0000519","EFO_1000158"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2338801","canonicalSmiles":"O=c1[nH]nc(CCc2ccc(C(F)(F)F)cc2)cc1O","inchiKey":"QBQMUMMSYHUDFM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LUVADAXISTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Luvadaxistat","TAK-831","TAK831","Tak-831"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2358147","canonicalSmiles":"CCC(=O)c1ccc2c(c1)N(CCCN1CCN(CCO)CC1)c1ccccc1S2.O=C(O)/C=C\\C(=O)O.O=C(O)/C=C\\C(=O)O","inchiKey":"TVPJGGZLZLUPOB-SPIKMXEPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARPHENAZINE MALEATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201328","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Proketazine"],"synonyms":["Carfenazine maleate","Carphenazine","Carphenazine dimaleate","Carphenazine maleate","NSC-71755","WY-2445"],"crossReferences":{"PubChem":["144206284"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL2364629","canonicalSmiles":"N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.N[C@@H]1c2cccnc2[C@H](OC(=O)N2CCC(n3c(=O)[nH]c4ncccc43)CC2)CC[C@H]1c1cccc(F)c1F.O.O.O.O=S(=O)(O)O","inchiKey":"SOGUOEZRYKUOHR-CQZKMDJHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEGEPANT SULFATE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2178422","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nurtec odt"],"synonyms":["Rimegepant sulfate"],"crossReferences":{"DailyMed":["rimegepant%20sulfate"]},"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2020 and is indicated for migraine disorder."}
{"id":"CHEMBL2402737","canonicalSmiles":"COc1cc(C(=O)O)ccc1NC(=O)[C@@H]1N[C@@H](CC(C)(C)C)[C@](C#N)(c2ccc(Cl)cc2F)[C@H]1c1cccc(Cl)c1F","inchiKey":"TVTXCJFHQKSQQM-LJQIRTBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IDASANUTLIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Idasanutlin","RG-7388","RG7388","RO-5503781","RO5503781"],"crossReferences":{"drugbank":["DB12325"]},"linkedTargets":{"rows":["ENSG00000141510","ENSG00000135679"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000403","MONDO_0007254","EFO_0000222","MONDO_0018906","EFO_0001378","EFO_0005952","EFO_0002429","EFO_0000519","EFO_1001951","EFO_0000479"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 11 investigational indications."}
{"id":"CHEMBL260091","canonicalSmiles":"C[C@@H](O)[C@H](NC(=O)c1ccc(C#Cc2ccc(CN3CCOCC3)cc2)cc1)C(=O)NO","inchiKey":"FQYBTYFKOHPWQT-VGSWGCGISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHIR-090","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHIR-090"],"crossReferences":{"drugbank":["DB07536"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL265502","canonicalSmiles":"Cc1ccc(C(=O)Nc2ccc(S(=O)(=O)O)c3cc(S(=O)(=O)O)cc(S(=O)(=O)O)c23)cc1NC(=O)c1cccc(NC(=O)Nc2cccc(C(=O)Nc3cc(C(=O)Nc4ccc(S(=O)(=O)O)c5cc(S(=O)(=O)O)cc(S(=O)(=O)O)c45)ccc3C)c2)c1","inchiKey":"FIAFUQMPZJWCLV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SURAMIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["FARMA-939","Farma","Fourneau","Metaret","NSC-34936","Naganol","Suramin","Suramine"],"crossReferences":{"PubChem":["11114098","124887029","144205598","170466101","26752197","26756673","50104860","544513","90341387"],"Wikipedia":["Suramin"],"drugbank":["DB04786"],"chEBI":["45906"]},"childChemblIds":["CHEMBL413376"],"linkedTargets":{"rows":["ENSG00000113578"],"count":1},"linkedDiseases":{"rows":["EFO_0003756","DOID_10113","EFO_0005044","HP_0001919","EFO_0000681","MONDO_0007254","EFO_0003060","MONDO_0008315","EFO_1001951","MONDO_0001187","EFO_0007294","EFO_0000673","EFO_0006544","EFO_0001378","EFO_1000796","EFO_1000158"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL280998","canonicalSmiles":"Oc1ccccc1O","inchiKey":"YCIMNLLNPGFGHC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CATECHOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pyrocatechol"],"crossReferences":{"PubChem":["11111004","144209515","144210473","17389988","50105556","57264281","85230987","90341698"],"Wikipedia":["Catechol"],"drugbank":["DB02232"],"chEBI":["18135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL292303","canonicalSmiles":"N[C@H](Cc1c[nH]c2ccccc12)C(=O)O","inchiKey":"QIVBCDIJIAJPQS-SECBINFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"D-TRYPTOPHAN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-Trp","D-Tryptophan"],"crossReferences":{"PubChem":["144204756","144211617","170465485","26753353"],"drugbank":["DB03225"],"chEBI":["16296"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039513","canonicalSmiles":"CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F","inchiKey":"ASUGUQWIHMTFJL-QGZVFWFLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DECERNOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adelatinib","Decernotinib","VRT-831509","VX-509"],"crossReferences":{"drugbank":["DB12566"]},"linkedTargets":{"rows":["ENSG00000105639"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3093499","canonicalSmiles":"COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(=O)CO)C[C@@H]3O[C@H]1C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)CCCC(=O)O)C2CCCCC2)[C@H](O)[C@H](C)O1","inchiKey":"CZXGBIFEWYVYJY-NPLULESDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-377202","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["L-377202","L-377202-000H"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL313113","canonicalSmiles":"CCOC/C=C/c1ccc(-c2nc(-c3ccc(NC(C)C)cc3)c(-c3ccc(NC(C)C)cc3)[nH]2)cc1","inchiKey":"RSJCLODJSVZNQA-BQYQJAHWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL313113","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB14069"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL316966","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@@H]2COP(=O)(O)O[C@H]2[C@H]1O","inchiKey":"IVOMOUWHDPKRLL-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYCLIC ADENOSINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Camp","Cyclic Adenosine Monophosphate","cyclic AMP"],"crossReferences":{"PubChem":["144207059","50105813","90340992"],"Wikipedia":["Cyclic_adenosine_monophosphate"],"drugbank":["DB02527"],"chEBI":["17489"]},"childChemblIds":["CHEMBL1363683"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186453","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)c1ccncc1","inchiKey":"BQTXJHAJMDGOFI-NJLPOHDGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186453","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["170466851"],"drugbank":["DB11487"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187246","canonicalSmiles":"CN(C)CCN(Cc1cccs1)c1ccccn1.CN(C)CCN(Cc1cccs1)c1ccccn1.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O","inchiKey":"OLGIEIJNOQGBSS-VQYXCCSOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHAPYRILENE FUMARATE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1411979","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Germany"],"classes":["Carcinogenicity"],"year":1979},"tradeNames":[],"synonyms":["Methapyrilene fumarate"],"crossReferences":{"PubChem":["144213936"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States and  Germany initially in 1979 due to Carcinogenicity."}
{"id":"CHEMBL321357","canonicalSmiles":"NCC[C@H](N)C(=O)O","inchiKey":"OGNSCSPNOLGXSM-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL321357","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["4252925"],"drugbank":["DB03817"],"chEBI":["48950"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL345524","canonicalSmiles":"O=C(OCCN1CCN(c2cccc(C(F)(F)F)c2)CC1)c1ccccc1Nc1ccnc2cc(C(F)(F)F)ccc12","inchiKey":"NWGGKKGAFZIVBJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ANTRAFENINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"year":1984},"tradeNames":[],"synonyms":["Antrafenine"],"crossReferences":{"Wikipedia":["Antrafenine"],"drugbank":["DB01419"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in France  in 1984."}
{"id":"CHEMBL3544913","canonicalSmiles":"NC(=O)[C@@H]1CC[C@H](c2ccc(OCc3ccccc3F)cc2)N1","inchiKey":"JESCETIFNOFKEU-SJORKVTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIXOTRIGINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIB-074","BIIB074","CNV-1014802","CNV1014802","GSK-1014802","GSK1014802","Raxatrigine","Vixotrigine"],"crossReferences":{"drugbank":["DB11706"]},"childChemblIds":["CHEMBL3544912"],"linkedTargets":{"rows":["ENSG00000169432"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_1000783","EFO_0000289","EFO_1001219","Orphanet_1956","MONDO_0002959","EFO_0009878"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3544979","drugType":"Small molecule","blackBoxWarning":false,"name":"IMISOPASEM MANGANESE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["403","GC-4403","Imisopasem manganese","Imisopasem manganese dichloride","M 40403","M-40403","M40403","SC-72325"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545154","canonicalSmiles":"C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1","inchiKey":"LPFWVDIFUFFKJU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POZIOTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HM 781-36","HM 781-36B","HM-781-36","HM-781-36B","HM781-36B","Hm-781-36b","NOV-120101","Poziotinib","Poziotinib hydrochloride"],"crossReferences":{"drugbank":["DB12114"]},"linkedTargets":{"rows":["ENSG00000146648","ENSG00000065361","ENSG00000178568","ENSG00000141736"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0001056","EFO_0005922","EFO_0000571","HP_0020174","EFO_0004284","MONDO_0007254","EFO_0003060","EFO_0000311"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545194","drugType":"Small molecule","blackBoxWarning":false,"name":"LGH-447","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGH-447","LGH447","Lgh-447","NVP-LGH477","PIM 447","PIM-447","Pim kinase inhibitor lgh447"],"linkedTargets":{"rows":["ENSG00000102096","ENSG00000137193","ENSG00000198355"],"count":3},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0000222","EFO_0001378"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545199","drugType":"Small molecule","blackBoxWarning":false,"name":"RG-7741","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GDC-0575","Rg-7741"],"linkedTargets":{"rows":["ENSG00000149554"],"count":1},"linkedDiseases":{"rows":["EFO_0000574"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545874","canonicalSmiles":"N[C@@H](C(=O)N[C@H]1C(=O)N2C(C(=O)O)=C(Cl)CC[C@H]12)c1ccccc1","inchiKey":"JAPHQRWPEGVNBT-IJLUTSLNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3545874","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04293"]},"childChemblIds":["CHEMBL3348864"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL355048","canonicalSmiles":"CC(C)N(C(=O)c1ccc(Cl)cc1Cl)c1cc(-c2ccccc2)sc1C(=O)O","inchiKey":"UKNZREOUDLFUFF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL355048","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03388"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3590674","canonicalSmiles":"O=C(c1cc(S(=O)(=O)Nc2ccccc2F)c(F)cc1Cl)N1CCN2CCC[C@@H]2C1","inchiKey":"AGPIHNZOZNKRGT-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-639","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-639","Abt-639 free base"],"crossReferences":{"drugbank":["DB15055"]},"childChemblIds":["CHEMBL3589557"],"linkedTargets":{"rows":["ENSG00000196557"],"count":1},"linkedDiseases":{"rows":["EFO_0005762"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707372","canonicalSmiles":"CC[C@H]1[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C3(C)CC3)C[C@H]2C(C)C)N2C[C@@H]1Oc1nc3cc(OC)ccc3nc1C(F)(F)CCCC[C@@H]1C[C@H]1OC(=O)N[C@@H](C(C)(C)C)C2=O","inchiKey":"MKDALIOACIEUJM-XCFCBFDASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXILAPREVIR","yearOfFirstApproval":2017,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["GS-9857","Voxilaprevir"],"crossReferences":{"DailyMed":["voxilaprevir"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2017 and is indicated for chronic hepatitis c virus infection and has 1 investigational indication."}
{"id":"CHEMBL392452","canonicalSmiles":"CC(C)[C@H]1SC(Nc2ccccc2F)=NC1=O","inchiKey":"OJJBBNIYQKFZDK-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL392452","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08771"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989510","canonicalSmiles":"CC(C)=CCN1CCC2(C)c3cc(O)ccc3CC1C2C.Cl","inchiKey":"OQGYMIIFOSJQSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAZOCINE HYDROCHLORIDE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL100116","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sosegon","Talwin","Talwin 50"],"synonyms":["Pentazocine hcl","Pentazocine hydrochloride"],"linkedTargets":{"rows":["ENSG00000147955"],"count":1},"linkedDiseases":{"rows":["EFO_0003843"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1969 and is indicated for pain."}
{"id":"CHEMBL3989756","canonicalSmiles":"O.O=[Mg].O=[Mg].O=[Mg].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O","inchiKey":"FPAFDBFIGPHWGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TALC","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL3990276","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sclerosol","Steritalc","Talc"],"synonyms":["E-553(III)","Huashifen","INS NO.553(III)","INS-553(III)","Pulvis talci","Purified talc","Talc","Talc powder","Talcum","Talcum powder"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1997 and is indicated for pleural effusion and has 4 investigational indications."}
{"id":"CHEMBL403772","canonicalSmiles":"CC(C)(C)c1nnc(C(=O)[C@@H]2CCCN2)o1","inchiKey":"YUKGJYBQODPVBL-ZETCQYMHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL403772","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL40422","canonicalSmiles":"CC(C)C[C@H](N)P(=O)(O)O","inchiKey":"HGCAUCAWEADMPM-RXMQYKEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCINE PHOSPHONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Leucine Phosphonic acid"],"crossReferences":{"drugbank":["DB02386"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411278","canonicalSmiles":"C[C@]12C[C@@]34C=CC(=O)[C@@](C)(CCC(=O)Nc5c(O)ccc(C(=O)O)c5O)[C@@H]3[C@H](C[C@@H]1C4)O2","inchiKey":"CSOMAHTTWTVBFL-OFBLZTNGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL411278","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08407"],"chEBI":["68236"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4112930","canonicalSmiles":"C[C@]12CCCN1CC1=NNC(=O)c3cc(F)cc4[nH]c2c1c34","inchiKey":"DENYZIUJOTUUNY-MRXNPFEDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PAMIPARIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGB-290","Bgb-290","Pamiparib"],"crossReferences":{"drugbank":["DB14769"]},"linkedTargets":{"rows":["ENSG00000143799","ENSG00000129484"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0003060","MONDO_0021639","MONDO_0001056","MONDO_0008170","MONDO_0007254","MONDO_0008315","EFO_0000519","MONDO_0021640","EFO_0000311","EFO_1000158"],"count":11},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL4297424","canonicalSmiles":"[82Rb]","inchiKey":"IGLNJRXAVVLDKE-OIOBTWANSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUBIDIUM RB-82","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1201326","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rubidium (82 rb)","Rubidium (rb-82)","Rubidium rb-82","Rubidium-82"],"description":"Small molecule drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL4297556","drugType":"Unknown","blackBoxWarning":false,"name":"MM-111","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mm 111","Mm-111"],"linkedTargets":{"rows":["ENSG00000065361","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["MONDO_0007254"],"count":1},"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297708","drugType":"Unknown","blackBoxWarning":false,"name":"BMS-986258","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Anti-tim-3 antibody bms-986258","BMS-986258","Bms-986258","ONO-7807"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297816","drugType":"Unknown","blackBoxWarning":false,"name":"PX-478","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Px 478","Px-478"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297831","drugType":"Antibody","blackBoxWarning":false,"name":"SPARTALIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ANTI-PD1 MONOCLONAL ANTIBODY PDR001","NVP-LZV184","PDR-001","PDR001","Pdr001","Spartalizumab"],"linkedTargets":{"rows":["ENSG00000188389"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0005922","EFO_0000756","EFO_0000681","Orphanet_44890","MONDO_0007254","EFO_0004252","EFO_0003060","EFO_0000311","MONDO_0001056","EFO_1001480","EFO_1000044","MONDO_0002120","EFO_0000389","EFO_0002517","EFO_0000182","EFO_0005537","MONDO_0008903","EFO_0000574","EFO_0001378","EFO_0000181"],"count":21},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL4297844","drugType":"Antibody","blackBoxWarning":false,"name":"TRASTUZUMAB DERUXTECAN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Enhertu"],"synonyms":["DS-8201","DS-8201a","Ds-8201a","Fam-trastuzumab deruxtecan-nxki","Trastuzumab deruxtecan","Trastuzumab deruxtecan-nxki"],"linkedTargets":{"rows":["ENSG00000198900","ENSG00000141736"],"count":2},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000637","EFO_0000503","MONDO_0007254","EFO_0005842","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0009708","MONDO_0001056","EFO_0008549","EFO_1000238","EFO_0004142","MONDO_0003219"],"count":15},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 4 approved and 7 investigational indications."}
{"id":"CHEMBL4297893","drugType":"Unknown","blackBoxWarning":false,"name":"AGS62P1","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGS62P1","ASP-1235","ASP1235","Ags62p1","Asp1235"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4298024","drugType":"Protein","blackBoxWarning":false,"name":"BINTRAFUSP ALFA","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["8L9YQ2N6PA","Bintrafusp alfa","M-7824","M7824","MSB-0011359C","MSB0011359C","Msb0011359c"],"linkedTargets":{"rows":["ENSG00000105329","ENSG00000120217","ENSG00000119699","ENSG00000092969"],"count":4},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000365","EFO_0000558","MONDO_0007254","EFO_0000305","MONDO_0001056","EFO_1000044","EFO_0000588","MONDO_0002974","MONDO_0008903","EFO_0000196","EFO_0001416","EFO_0000616","EFO_0002618","EFO_0002916","MONDO_0008170","EFO_1001968","EFO_0005221","EFO_0003060","MONDO_0008315","EFO_0001663","EFO_1001961","EFO_0003863","EFO_0000304","EFO_1000581","EFO_0000702","EFO_0006544","MONDO_0024880","EFO_0000181"],"count":29},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 22 investigational indications."}
{"id":"CHEMBL4298063","drugType":"Unknown","blackBoxWarning":false,"name":"CILIARY NEUROTROPHIC FACTOR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciliary neurotrophic factor","Human cntf","Nt-501"],"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL4300945","canonicalSmiles":"Cc1cnc(C[S@@+]([O-])c2nc3ccccc3[nH]2)c(C)c1OCC1COC(C)(C)OC1","inchiKey":"DWDKHTXMLSZGDL-SSEXGKCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZELOPRAZOLE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azeloprazole"],"childChemblIds":["CHEMBL4297375"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL444814","canonicalSmiles":"NC(=O)NCCC[C@H](N)C(=O)O","inchiKey":"RHGKLRLOHDJJDR-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"L-CITRULLINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Citrulline","L-citrulline","NSC-27425"],"crossReferences":{"Wikipedia":["Citrulline"],"drugbank":["DB00155"],"chEBI":["16349"]},"childChemblIds":["CHEMBL4297667"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 16 investigational indications."}
{"id":"CHEMBL4541964","canonicalSmiles":"O=C(O)Cc1ccc(Cc2cc(-c3cccc(Cl)c3)nc(C(F)(F)F)c2)cc1","inchiKey":"LTSUMTMGJHPGFX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZATOLMILAST","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BPN-14770","BPN14770","Bpn-14770","Bpn14770","Zatolmilast"],"linkedTargets":{"rows":["ENSG00000113448"],"count":1},"linkedDiseases":{"rows":["MONDO_0004975","Orphanet_908"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL458049","canonicalSmiles":"COc1ccc(CCC(=O)O)cc1OC","inchiKey":"LHHKQWQTBCTDQM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3,4-Dimethoxy-Hydrocinnamic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dimethoxy-Hydrocinnamic Acid","3,4-Dimethoxyhydrocinnamic Acid"],"crossReferences":{"PubChem":["26659733"],"drugbank":["DB04208"],"chEBI":["44235"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594401","canonicalSmiles":"CC1=NN(c2ccc3c(c2)CCCC3)C(=O)/C1=N\\Nc1cccc(-c2ccc(C(=O)O)o2)c1O","inchiKey":"BDGGFTDRPHKXFC-QYQHSDTDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HETROMBOPAG","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hetrombopag","SHR-8735","SHR8735"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594448","canonicalSmiles":"CCO[C@H]1CCN(Cc2c(OC)cc(C)c3[nH]ccc23)[C@H](c2ccc(C(=O)O)cc2)C1","inchiKey":"RENRQMCACQEWFC-UGKGYDQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IPTACOPAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Iptacopan","LNP-023","LNP023","Lnp023"],"childChemblIds":["CHEMBL4643495"],"linkedTargets":{"rows":["ENSG00000243649"],"count":1},"linkedDiseases":{"rows":["EFO_0005761","Orphanet_2134","EFO_0004254","EFO_0001365","EFO_0001421","MONDO_0002462","EFO_0004194","Orphanet_447","Orphanet_329918"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4650378","drugType":"Small molecule","blackBoxWarning":false,"name":"AZOXIMER BROMIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azoximer bromide"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4650513","drugType":"Protein","blackBoxWarning":false,"name":"GOFLIKICEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Goflikicept","RPH 104","RPH-104","Rph-104"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4802149","canonicalSmiles":"Cc1cc(C2CCCCC2)n(OCOP(=O)(O)O)c(=O)c1","inchiKey":"NTKBXPWLNROYPE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSCICLOPIROX","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ciclopirox-pom","Fosciclopirox"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL484","canonicalSmiles":"Nc1ncnc2c1ncn2CCOCP(=O)(O)O","inchiKey":"SUPKOOSCJHTBAH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADEFOVIR","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adefovir","GS 0393","GS-0393"],"crossReferences":{"PubChem":["144205435","29216223"],"Wikipedia":["Adefovir"],"drugbank":["DB13868"]},"childChemblIds":["CHEMBL2386204"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL518383","canonicalSmiles":"O=C(Nc1ccc(F)cc1)c1n[nH]cc1NC(=O)c1c(F)cccc1F","inchiKey":"BDRDBXXWQDFXEC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL518383","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08138"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521","canonicalSmiles":"CC(C)Cc1ccc(C(C)C(=O)O)cc1","inchiKey":"HEFNNWSXXWATRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"IBUPROFEN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aches-n-pain","Advil","Advil liqui-gels","Advil migraine liqui-gels","Anadin joint pain","Anadin liquifast","Anadin period pain relief","Anadin ultra","Apsifen","Apsifen-f","Arthrofen 200","Arthrofen 400","Arthrofen 600","Brufen ret","Caldolor","Cap-profen","Children's advil","Children's advil-flavored","Children's elixsure","Children's ibuprofen","Children's motrin","Co-op","Codafen continus","Cuprofen for child","Cuprofen plus","Deep relief","Ebufac","Femafen","Fenbid","Fenbid fte","Fenpaed","Feverfen","Fleximex","Ibu-slo","Ibu-tab","Ibu-tab 200","Ibucalm","Ibuderm","Ibufac","Ibugel","Ibugel fte","Ibular","Ibuleve","Ibumed","Ibumetin","Ibumousse","Ibuprin","Ibuprofen","Ibuprohm","Ibuspray","Ibutime","Inabrin","Infant's advil","Inoven","Isisfen","Junifen","Junior strength advil","Junior strength ibuprofen","Junior strength motrin","Lidifen","Lidifen-f","Lobufen","Mandafen","Manorfen","Maxa-gesic","Medipren","Midol","Midol liquid gels","Migrafen","Motrin","Motrin ib","Motrin migraine pain","Novaprin","Nuprin","Nurofen 400","Nurofen back pain sr","Nurofen child","Nurofen for child","Nurofen plus","Nurofen recovery","Nurofen sinus","Nurofen solb","Orbifen","Pacifene","Paxofen","Pedea","Pediatric advil","Phensic","Phor pain","Phorpain","Phorpain max strgh","Profen","Proflex","Proflex sr","Relcofen","Rimafen","Rufen","Seclodin","Suspren","Tab-profen"],"synonyms":["Burana","IB-100","IP-82","Ibuprofen","Ibuprofenum","M01AE01","NSC-256857","RD 13621","U-18,573","U-18573"],"crossReferences":{"DailyMed":["ibuprofen","ibuprofen%20lysine","ibuprofen%20sodium"],"PubChem":["104171175","124880372","124880375","138460","144203721","144208582","144213146","170464979","174007269","26747223","26747224","26752326","50105276","50105277","50105278","56422436","85231082","855602","90341584"],"TG-GATEs":["72"],"Wikipedia":["Ibuprofen"],"drugbank":["DB01050"],"chEBI":["5855"]},"childChemblIds":["CHEMBL4594450","CHEMBL3989408","CHEMBL1201141","CHEMBL1241153"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0003869","EFO_1001139","EFO_0007486","MONDO_0002009","EFO_0009610","HP_0001643","EFO_1001919","HP_0012228","HP_0011868","EFO_0003964","EFO_0006803","HP_0100543","EFO_0003103","EFO_0003931","EFO_0000771","EFO_0000544","EFO_0009582","EFO_1000786","EFO_0009093","EFO_0004263","EFO_1001366","EFO_0004616","EFO_1000632","HP_0003419","EFO_1000652","EFO_1000854","EFO_0009620","Orphanet_379","EFO_1001250","EFO_0005854","EFO_1001476","EFO_0001074","HP_0012532","EFO_0005856","EFO_0010072","Orphanet_3389","EFO_1000782","EFO_0009516","EFO_0005757","Orphanet_98896","MONDO_0100431","EFO_0000546","MP_0001914","HP_0003326","MP_0001845","MONDO_0100096","HP_0030833","EFO_0003957","EFO_0000731","EFO_0004209","HP_0100607","EFO_0007328","MONDO_0002258","EFO_0000668","EFO_1001158","EFO_0003767","EFO_0003943","EFO_1000843","EFO_0002970","EFO_0006834","HP_0002373","Orphanet_232","MONDO_0100342","MONDO_0024290","EFO_0000464","EFO_0005252","EFO_0009846","MONDO_0007254","EFO_1000637","EFO_0002950","HP_0002829","MONDO_0005277","HP_0004398","Orphanet_70589","EFO_1001216","EFO_0003938","EFO_0004143","EFO_0005279","EFO_0003917","EFO_0000694","EFO_0000685","EFO_0000772","EFO_0000545","EFO_1001757","EFO_0003832","HP_0001945","EFO_0003958","EFO_0003929","EFO_0000319","HP_0003418","EFO_0001073","EFO_0003843","HP_0002315","EFO_0005755","EFO_0002609","EFO_0000537","EFO_0007214","EFO_1001460","MONDO_0005301","EFO_0001068","EFO_0000649","MONDO_0005147","EFO_0000764","MONDO_0004975","EFO_1001891","EFO_0000706","EFO_0005611","EFO_0003918","MONDO_0005178","EFO_0003944","MONDO_0024880","EFO_0009615"],"count":112},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 21 approved and 58 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL526688","canonicalSmiles":"Cc1cc(N)nc(C[C@H]2CNC[C@@H]2NCCNCc2cccc(Cl)c2)c1","inchiKey":"VWCMAGONQJHIJZ-LPHOPBHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL526688","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08019"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL54661","canonicalSmiles":"OCCN1CCN(CC/C=C2/c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"NJMYODHXAKYRHW-DVZOWYKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUPENTIXOL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Flupenthixol","Flupentixol","LC 44","LC-44","N-7009"],"crossReferences":{"PubChem":["144205556","170465964","26755684","29216405","50111069","50111070","90341514"],"drugbank":["DB00875"],"chEBI":["10454"]},"childChemblIds":["CHEMBL1496351","CHEMBL1256995"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL562967","canonicalSmiles":"CC(C)C(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)[C@](C)(F)[C@@H]1OC(=O)C(C)C","inchiKey":"MLESJYFEMSJZLZ-MAAOGQSESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MERICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Ro5024048; r7128"],"synonyms":["3',5'-DIISOBUTYRYL PSI 6130","Mericitabine","PSI 6130 DIISOBUTYRATE","R 7128","R-7128","R7128","RG 7128","RO-5024048","RO5024048"],"crossReferences":{"drugbank":["DB12045"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL57375","canonicalSmiles":"O=C(Nc1nccs1)c1cccc(CN2C(=O)N(Cc3cccc(C(=O)Nc4nccs4)c3)[C@H](Cc3ccccc3)[C@H](O)[C@@H](O)[C@H]2Cc2ccccc2)c1","inchiKey":"JDALSSGOBMTZEP-NWJWHWDBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL57375","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02702"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL576","canonicalSmiles":"O=C(O)CCC(=O)O","inchiKey":"KDYFGRWQOYBRFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SUCCINIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Amber acid","Dihydrofumaric acid","E363","FEMA NO. 4719","NSC-106449","Succinic acid","Succinicum acidum"],"crossReferences":{"PubChem":["144205165","144209116","144213564","170465738","29215296"],"Wikipedia":["Succinic_acid"],"drugbank":["DB00139"],"chEBI":["15741"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL578390","canonicalSmiles":"CCCCCCCCC/C(=C\\C1=C(C)C(=O)C(OC)=C(OC)C1=O)C(=O)O","inchiKey":"AALSSIXXBDPENJ-FYWRMAATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"APX-3330","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APX 3330","APX-3330","APX3330","Apx-3330","Apx3330","E 3330","E-3330"],"linkedTargets":{"rows":["ENSG00000100823"],"count":1},"linkedDiseases":{"rows":["EFO_0009322","EFO_0009321","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL58792","canonicalSmiles":"COc1ccccc1N1CCN(CCCC(=O)c2ccc(F)cc2)CC1","inchiKey":"IRYFCWPNDIUQOW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUANISONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fluanisone","MD 2028","MD-2028","NSC-170977","R 2028","R 2167","R-2028","R-2167"],"crossReferences":{"PubChem":["144204543","7972459"],"Wikipedia":["Fluanisone"],"drugbank":["DB13665"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL6","canonicalSmiles":"COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c1ccc(Cl)cc1","inchiKey":"CGIGDMFJXJATDK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"INDOMETHACIN","yearOfFirstApproval":1965,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Artracin","Artracin sr","Berlind 75 ret","Flexin-25 continus","Flexin-50 continus","Flexin-75 continus","Imbrilon","Indo-lemmon","Indo-paed","Indocid ret","Indocid-r","Indocin","Indocin sr","Indoderm","Indoflex","Indolar","Indolar sr","Indomax-25","Indomax-75 sr","Indomethacin","Indomod","Indoptol","Indotard mr 75","Ledmecin","Maximet sr","Mobilan","Pardelprin mr","Rheumacin la","Rimacid","Slo-indo","Tivorbex"],"synonyms":["Aconip","Durametacin","Indometacin","Indometacin farnesil","Indometacinum","Indomethacin","NSC-757061","NSC-77541","Reumacide"],"crossReferences":{"DailyMed":["indomethacin"],"PubChem":["11111328","11111329","11113361","124880453","124880455","124880457","124880458","144206660","144208989","144210586","170464705","17389851","174007200","26747086","26747087","26751593","50100255","50104238","50104239","50126367","56422212","85231093","856012","90340917"],"TG-GATEs":["15"],"Wikipedia":["Indometacin"],"drugbank":["DB00328"],"chEBI":["49662"]},"childChemblIds":["CHEMBL2028292","CHEMBL3989410","CHEMBL4590319"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_1000172","EFO_1001896","MONDO_0003005","EFO_0000278","MONDO_0024290","EFO_0004274","HP_0001643","EFO_0005252","MONDO_0007254","EFO_1001951","HP_0002829","EFO_1000318","EFO_0009582","EFO_0000389","EFO_0000673","EFO_1000652","HP_0001518","EFO_0000196","EFO_0003917","EFO_0005752","EFO_0000685","EFO_0010072","EFO_0003898","EFO_0000319","EFO_0003843","EFO_0005755","MONDO_0008315","MONDO_0012511","EFO_1001412","MP_0001845","HP_0003326","MP_0001914","MONDO_0100096","Orphanet_79292","MONDO_0003937","MONDO_0004975","EFO_0000199","MONDO_0004979","EFO_0000342","MONDO_0005178","EFO_0000181","MONDO_0024475"],"count":42},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1965 and has 12 approved and 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL603","canonicalSmiles":"COc1cc(C(=O)NS(=O)(=O)c2ccccc2C)ccc1Cc1cn(C)c2ccc(NC(=O)OC3CCCC3)cc12","inchiKey":"YEEZWCHGZNKEEK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZAFIRLUKAST","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accolate","Zafirlukast"],"synonyms":["ICI 204,219","ICI-204219","Ici-204,219","Zafirlukast"],"crossReferences":{"DailyMed":["zafirlukast"],"PubChem":["144205729","170464673","26719823","26757966","49681658"],"Wikipedia":["Zafirlukast"],"drugbank":["DB00549"],"chEBI":["10100"]},"linkedTargets":{"rows":["ENSG00000173198"],"count":1},"linkedDiseases":{"rows":["HP_0006536","MONDO_0008170","MONDO_0007254","MONDO_0004979"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for airway obstruction and asthma and has 2 investigational indications."}
{"id":"CHEMBL684","canonicalSmiles":"CCN(CC)C(=O)N1CCN(C)CC1","inchiKey":"RCKMWOKWVGPNJF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIETHYLCARBAMAZINE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Camin","Diethylcarbamazine","Hetrazan"],"crossReferences":{"Wikipedia":["Diethylcarbamazine"],"drugbank":["DB00711"],"chEBI":["4527"]},"childChemblIds":["CHEMBL937"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for helminthiasis and has 3 investigational indications."}
{"id":"CHEMBL97893","canonicalSmiles":"O=P(O)(O)OC[C@H]1O[C@](O)(COP(=O)(O)O)[C@@H](O)[C@@H]1O","inchiKey":"RNBGYGVWRKECFJ-ARQDHWQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FOSFRUCTOSE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fosfructose"],"crossReferences":{"PubChem":["29218079"],"drugbank":["DB04551"],"chEBI":["28013"]},"childChemblIds":["CHEMBL3945772","CHEMBL2146112"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL99842","canonicalSmiles":"CC(=O)Nc1nccc(-c2c(C)nc3ccccn23)n1","inchiKey":"ZCRPPLDDHBLUES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL99842","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
